< Back to Front Page Text size +

Today's Globe: Biotech Council, bipolar boom, Ashby school, executive function

Posted by Elizabeth Cooney September 4, 2007 06:52 AM

As the Massachusetts Biotechnology Council's new leader faces ethics questions, some members say they have become disenchanted with the trade group, including its increasing focus on lobbying, a high staff turnover rate, and the low number of top executives serving on its board.

The diagnosis of bipolar disorder in children and adolescents has risen fortyfold since 1994, according to a new study released yesterday. But researchers partly attributed the dramatic rise to doctors overdiagnosing the serious psychiatric disorder.

When Ashby Academy, a boarding school specializing in children with Asperger's syndrome, abruptly closed last week, it left families from around the country stunned and wondering where their children will attend school this year - or whether they will see their tuition money again.

If you've never heard of executive function, brace yourself. It's bursting onto the educational scene, Child Caring columnist Barbara F. Meltz writes.

add your comment
Required
Required (will not be published)

This blogger might want to review your comment before posting it.

about white coat notes We post updates every weekday about the region's hospitals, labs and medical schools – covering everything from the latest research findings to what's on the minds of the innovative doctors, nurses and scientists who work here. Send news items and tips to whitecoat@globe.com

Contributors

blogger

Elizabeth Cooney covers health for the Worcester Telegram & Gazette. She previously reported on business and was an editor at the paper. Earlier in her career, she edited medical books and journals at Little, Brown, and worked for Boston magazine.

Boston Globe Health and Science staff:

archives